Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy

Paediatric Anaesthesia

Volumn 18, Issue 3, 2008, Pages 251-255

  Muenster, Tino ^a   Forst, Juergen ^a   Goerlitz, Peter ^b   Schmitt, Hubert J ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Friedrich Alexander University Erlangen Nuremberg ^*  (Germany)

Author keywords

Antagonists; Muscular dystrophy; Neuromuscular block; Pyridostigmine

Indexed keywords

GLYCOPYRRONIUM BROMIDE; MUSCLE RELAXANT AGENT; PYRIDOSTIGMINE; ROCURONIUM; SODIUM CHLORIDE;

ABSENCE OF SIDE EFFECTS; ACCELEROMYOGRAPHY; ADDUCTOR POLLICIS MUSCLE; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; ELECTIVE SURGERY; ENDOTRACHEAL INTUBATION; HAND MUSCLE; HUMAN; MALE; MYOGRAPHY; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; RANK SUM TEST; SCHOOL CHILD; SCOLIOSIS;

ADOLESCENT; ADULT; ANDROSTANOLS; CHILD; CHOLINESTERASE INHIBITORS; ELECTROMYOGRAPHY; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PYRIDOSTIGMINE BROMIDE; TIME FACTORS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION;

EID: 38549131793     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2008.02417.x     Document Type: Article

References (12)

1. Buzello W, Huttarsch H. Muscle relaxation in patients with Duchenne's muscular dystrophy. Use of vecuronium in two patients. Br J Anaesth 1988 60 : 228 231.
2. Ririe DG, Shapiro F, Sethna NF. The response of patients with Duchenne's muscular dystrophy to neuromuscular blockade with vecuronium. Anesthesiology 1998 88 : 351 354.
3. Tobias DT, Atwood R. Mivacurium in children with Duchenne muscular dystrophy. Paediatr Anaesth 1994 4 : 57 60.
4. Wick S, Muenster T, Schmidt J et al. Onset and duration of rocuronium-induced neuromuscular blockade in patients with Duchenne muscular dystrophy. Anesthesiology 2005 102 : 915 919.
5. Schmidt J, Muenster T, Wick S et al. Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy. Br J Anaesth 2005 95 : 769 772.
6. Viby-Mogensen J, Engbaek J, Eriksson LI et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996 40 : 59 74.
7. Miller RD, Van Nyhuis LS, Eger EI II. et al. Comparative times to peak effect and durations of action of neostigmine and pyridostigmine. Anesthesiology 1974 41 : 27 33.
8. Donati F, Ferguson A, Bevan DR. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine. Anesth Analg 1983 62 : 314 316.
9. Naguib M, Abdulatif M, al-Ghamdi A. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade. Anesthesiology 1993 79 : 739 745.
10. Bowman WC. Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth Analg 1980 59 : 935 943.
11. Buzello W, Krieg N, Schlickewei A. Hazards of neostigmine in patients with neuromuscular disorders. Report of two cases. Br J Anaesth 1982 54 : 529 534.
12. Baker T, Stanec A. Drug actions at mammalian motor nerve endings: the suppression of neostigmine-induced fasciculations by vecuronium and isoflurane. Anesthesiology 1987 67 : 942 947.